Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 31, 2013 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Host Fourth Quarter and Full Year 2012 Financial Results Conference Call and Webcast on Thursday, February 21 at 5:00 p.m. ET

SAN RAFAEL, Calif., Jan. 31, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer of BioMarin, will host a...
January 18, 2013 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

SAN RAFAEL, Calif., Jan. 18, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on January 15, 2013, the compensation committee of BioMarin's board of directors...
January 07, 2013 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Acquires Zacharon Pharmaceuticals

Lead Program Focused on the Oral Treatment of MPS III Acquisition Augments Existing Analytical Capabilities and Expertise in Glycobiology SAN RAFAEL, Calif., Jan. 7, 2013 (GLOBE NEWSWIRE) --...
January 03, 2013 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the J.P. Morgan Healthcare Conference

SAN RAFAEL, Calif., Jan. 3, 2013 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Jean-Jacques Bienaimé, Chief Executive Officer at BioMarin, will present a...
December 21, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

SAN RAFAEL, Calif., Dec. 21, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on December 18, 2012, the compensation committee of BioMarin's board of directors...
November 27, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Host a Research and Development Day on December 6th

SAN RAFAEL, Calif., Nov. 27, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) will host a Research and Development Day for the investment community on Thursday, December 6, 2012...
November 27, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the Deutsche Bank BioFEST Conference

SAN RAFAEL, Calif., Nov. 27, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Dan Spiegelman, Chief Financial Officer at BioMarin, will present a company update...
November 20, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the Piper Jaffray Healthcare Conference

SAN RAFAEL, Calif., Nov. 20, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Joshua Grass, Senior Vice President of Corporate and Business Development at...
November 19, 2012 16:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

NOVATO, Calif., Nov. 19, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that on November 15, 2012, the compensation committee of BioMarin's board of directors...
November 09, 2012 09:00 ET | Source: BioMarin Pharmaceutical Inc.

BioMarin to Present at the Credit Suisse Healthcare Conference

SAN RAFAEL, Calif., Nov. 9, 2012 (GLOBE NEWSWIRE) -- BioMarin Pharmaceutical Inc. (Nasdaq:BMRN) today announced that Dan Maher, Senior Vice President of Product Development at BioMarin, will present a...